In recent years, an increasing number of studies have found that HULC polymorphisms are associated with susceptibility to various diseases, such as hepatocellular cancer and colorectal cancer (Shaker et al., 2017; Wang et al., 2018). Here, HULC is linked to hepatocellular carcinoma.